Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
Federal Trade Commission
McKesson
Baxter
Citi
Deloitte
US Department of Justice
Accenture

Generated: June 18, 2018

DrugPatentWatch Database Preview

Rocuronium bromide - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for rocuronium bromide and what is the scope of rocuronium bromide patent protection?

Rocuronium bromide
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Institutional, Sagent Pharms, Sandoz Inc, Tamarang, Teva Pharms, West Ward Pharm Corp, and Organon Usa Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for rocuronium bromide. Fifteen suppliers are listed for this compound.
Pharmacology for rocuronium bromide
Synonyms for rocuronium bromide
(2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-morpholin-4-yl-16-(1-prop-2-en-1-ylpyrrolidinium-1-yl)androstane bromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide
1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium bromide
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-14-(ACETYLOXY)-5-HYDROXY-2,15-DIMETHYL-4-(MORPHOLIN-4-YL)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-13-YL]-1-(PROP-2-EN-1-YL)PYRROLIDIN-1-IUM BROMIDE
1-[(2B,3A,5A,16B,17B)-17-(ACETYLOXY)-3-HYDROXY-2-(4-MORPHOLINYL)ANDROSTAN-16-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE
1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(4-morpholinyl)-androstan-16-yl]-1(2-propenyl)pyrrolidinium bromide
1-[17B-(ACETYLOXY)-3A-HYDROXY2B-(4-MORPHOLINYL)-5A-ANDROSTAN-16B-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE
1-[17BETA-(ACETYLOXY)-3ALPHA-HYDROXY-2BETA-(4-MORPHOLINYL)-5ALPHA-ANDROSTAN-16BETA-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE
1-[17beta-acetyloxy-3alpha-hydroxy-2beta-(4-morpholinyl)-5alpha-androstan-16beta-yl]-1-(2-propenyl)pyrrolidinium bromide
1-Allyl-1-(3alpha,17beta-dihydroxy-2beta-morpholino-5alpha-androstan-16beta-yl)pyrrolidinium bromide, 17-acetate
111GE014
119302-91-9
17beta-(acetyloxy)-3alpha-hydroxy-2beta-(morpholin-4-yl)-16beta-[1-(prop-2-en-1-yl)pyrrolidinium-1-yl]-5alpha-androstane
17beta-acetoxy-16beta-(1-allylpyrrolidinium-1-yl)-3alpha-hydroxy-2beta-(morpholin-4-yl)-5alphaandrostane
AC-2004
AC1L9B0Y
AKOS025149635
AN-14416
API0024407
AS-13323
BC004036
BC222603
BCP0726000028
BROMOROCURONIUM
C-23335
CAS-119302-91-9
CC-34280
cc-624
CHEBI:8885
CHEMBL1200648
CR-015
CR0018
CS-1467
D00765
DR003367
DSSTox_CID_3566
DSSTox_GSID_23566
DSSTox_RID_77083
DTXSID7023566
Eslax
Esmeron
HY-17440
I65MW4OFHZ
NCGC00167433-01
ORG 9426
Org-9426
org9426
OYTJKRAYGYRUJK-FMCCZJBLSA-M
PL042932
PubChem15778
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
Q-101010
R0099
Rocuroium Bromide
Rocuronium (Bromide)
Rocuronium bromide (JAN/USAN/INN)
Rocuronium bromide [USAN:USP:INN:BAN]
Rocuronium bromide, >=98% (perchloric acid titration)
Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard
Rocuronium bromide, United States Pharmacopeia (USP) Reference Standard
Rocuronium for peak identification, European Pharmacopoeia (EP) Reference Standard
Rocuroniun bromide
s1397
SC-21811
SCHEMBL41320
ST24049126
Tox21_112437
UNII-I65MW4OFHZ
W-5167
Zemuron
Zemuron (TN)

US Patents and Regulatory Information for rocuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-003 Mar 17, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078519-001 Nov 26, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078651-001 Dec 29, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 206206-001 Apr 12, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for rocuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-001 Mar 17, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-003 Mar 17, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-002 Mar 17, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
US Army
Chinese Patent Office
Baxter
Daiichi Sankyo
Johnson and Johnson
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.